Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 4:25 PM View:  | Seer, Inc. (SEER) | 12-Jun-24 | Grant | 58,178 | -- | -- | 8% 725.85K to 784.02K | |
| 17-Jun-22 6:42 PM View: | Seer, Inc. (SEER) | 15-Jun-22 | Grant | 9,945 | -- | -- | 1% 692.46K to 702.4K | |
| 03-Feb-23 10:00 PM View: | Moderna, Inc. (MRNA) | 05-May-22 | Gift | 703 | -- | -- | (< 1%) 11.51M to 11.51M | |
| 02-May-22 4:45 PM View: | Moderna, Inc. (MRNA) | 28-Apr-22 | Option Exercise | 703 | -- | -- | < 1% 11.51M to 11.51M | |
| 12-Jan-22 6:44 PM View: | Seer, Inc. (SEER) | 10-Jan-22 | Conversion | 327,102 | -- | -- | 90% 365.36K to 692.46K | |
| 09-Dec-20 8:23 PM View: | Seer, Inc. (SEER) | 08-Dec-20 | Conversion | 205,831 | -- | -- | 129% 159.53K to 365.36K | |
| 19-Nov-20 5:55 PM View: | Korro Bio, Inc. (KRRO) | 17-Nov-20 | Gift | 56,912 | -- | -- | (19%) 296.93K to 240.02K | |
| 06-May-20 7:31 PM View: | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 668 | -- | -- | 5% 14.5K to 15.17K | |
| 17-Oct-19 6:01 AM View: | Rubius Therapeutics, Inc. (RUBY) | 14-Oct-19 | Option Exercise | 7,500 | $0.15 | $1,125.00 | 100% 0 to 7.5K | |
| 17-Oct-19 6:01 AM View: | Rubius Therapeutics, Inc. (RUBY) | 14-Oct-19 | Market Option Sale (Planned) | 7,500 | $8.52 | $63,874.50 | (100%) 7.5K to 0 | (68%) |
| 17-Jul-19 4:14 PM View: | Rubius Therapeutics, Inc. (RUBY) | 15-Jul-19 | Option Exercise | 7,500 | $0.15 | $1,125.00 | 100% 0 to 7.5K | |
| 17-Jul-19 4:14 PM View: | Rubius Therapeutics, Inc. (RUBY) | 15-Jul-19 | Market Option Sale (Planned) | 7,500 | $14.94 | $112,048.00 | (100%) 7.5K to 0 | 4% |
| 17-Apr-19 8:42 PM View: | Rubius Therapeutics, Inc. (RUBY) | 15-Apr-19 | Option Exercise | 7,500 | $0.15 | $1,125.00 | 100% 0 to 7.5K | |
| 17-Apr-19 8:42 PM View: | Rubius Therapeutics, Inc. (RUBY) | 15-Apr-19 | Market Option Sale (Planned) | 7,500 | $17.57 | $131,799.00 | (100%) 7.5K to 0 | 18% |
| 18-Jan-19 4:36 PM View: | Rubius Therapeutics, Inc. (RUBY) | 14-Jan-19 | Option Exercise | 7,500 | $0.15 | $1,125.00 | 100% 0 to 7.5K | |
| 18-Jan-19 4:36 PM View: | Rubius Therapeutics, Inc. (RUBY) | 14-Jan-19 | Market Option Sale (Planned) | 7,500 | $14.59 | $109,444.00 | (100%) 7.5K to 0 | 2% |
| 13-Dec-18 4:27 PM View: | Moderna, Inc. (MRNA) | 11-Dec-18 | Conversion | 4,559 | -- | -- | < 1% 11.5M to 11.51M | |
| 30-Aug-16 4:36 PM View: | Dnib Unwind, Inc. (BIND) | 26-Aug-16 | Option Exercise | 15,000 | $0.44 | $6,600.00 | 2% 723.42K to 738.42K | |
| 11-Feb-16 4:27 PM View: | Advanced Cell Technology Inc. (ACTC) | 10-Feb-16 | Disposition (change in control) | 51,000 | $8.50 | $433,500.00 | (100%) 51.0K to 0 | |
| 04-Jan-16 4:45 PM View: | Advanced Cell Technology Inc. (ACTC) | 31-Dec-15 | Grant | 1,250 | -- | -- | 2% 51.0K to 52.25K | |
| 01-Oct-15 4:07 PM View: | Advanced Cell Technology Inc. (ACTC) | 30-Sep-15 | Grant | 1,250 | -- | -- | 3% 49.75K to 51.0K | |
| 02-Jul-15 4:03 PM View: | Advanced Cell Technology Inc. (ACTC) | 30-Jun-15 | Grant | 1,250 | -- | -- | 3% 48.5K to 49.75K | |
| 01-Apr-15 4:18 PM View: | Advanced Cell Technology Inc. (ACTC) | 31-Mar-15 | Grant | 1,250 | -- | -- | 3% 47.25K to 48.5K | |
| 02-Jan-15 4:07 PM View: | Advanced Cell Technology Inc. (ACTC) | 31-Dec-14 | Grant | 1,250 | -- | -- | 3% 46.0K to 47.25K | |
| 01-Oct-14 4:28 PM View: | Advanced Cell Technology Inc. (ACTC) | 30-Sep-14 | Grant | 1,250 | -- | -- | 3% 44.75K to 46.0K | |
| 02-Jul-14 11:05 AM View: | Advanced Cell Technology Inc. (ACTC) | 30-Jun-14 | Grant | 125,000 | -- | -- | 3% 4.35M to 4.47M | |
| 02-Apr-14 10:57 AM View: | Advanced Cell Technology Inc. (ACTC) | 31-Mar-14 | Grant | 125,000 | -- | -- | 3% 4.22M to 4.35M | |
| 03-Jan-14 3:35 PM View: | Advanced Cell Technology Inc. (ACTC) | 31-Dec-13 | Grant | 125,000 | -- | -- | 3% 4.1M to 4.22M | |
| 02-Oct-13 2:31 PM View: | Advanced Cell Technology Inc. (ACTC) | 30-Sep-13 | Grant | 125,000 | -- | -- | 3% 3.98M to 4.1M | |
| 01-Jul-13 4:18 PM View: | Advanced Cell Technology Inc. (ACTC) | 28-Jun-13 | Grant | 125,000 | -- | -- | 3% 3.85M to 3.98M | |
| 05-Jun-13 5:56 PM View: | Invivo Therapeutics Holding... (NVIV) | 05-Jun-13 | Sale (Planned) | 2,500 | $3.91 | $9,775.00 | (< 1%) 7.44M to 7.43M | |
| 05-Jun-13 5:56 PM View: | Invivo Therapeutics Holding... (NVIV) | 04-Jun-13 | Sale (Planned) | 2,500 | $3.90 | $9,754.00 | (< 1%) 7.44M to 7.44M | |
| 05-Jun-13 5:56 PM View: | Invivo Therapeutics Holding... (NVIV) | 03-Jun-13 | Sale (Planned) | 2,500 | $3.37 | $8,432.00 | (< 1%) 7.44M to 7.44M | |
| 31-May-13 6:06 PM View: | Invivo Therapeutics Holding... (NVIV) | 31-May-13 | Sale (Planned) | 2,500 | $3.39 | $8,475.00 | (< 1%) 7.44M to 7.44M | |
| 31-May-13 6:06 PM View: | Invivo Therapeutics Holding... (NVIV) | 30-May-13 | Sale (Planned) | 2,500 | $3.40 | $8,500.00 | (< 1%) 7.44M to 7.44M | |
| 31-May-13 6:06 PM View: | Invivo Therapeutics Holding... (NVIV) | 29-May-13 | Sale (Planned) | 2,500 | $3.13 | $7,825.00 | (< 1%) 7.45M to 7.44M | |
| 28-May-13 5:25 PM View: | Invivo Therapeutics Holding... (NVIV) | 28-May-13 | Sale (Planned) | 2,500 | $3.03 | $7,570.00 | (< 1%) 7.45M to 7.45M | |
| 28-May-13 5:25 PM View: | Invivo Therapeutics Holding... (NVIV) | 24-May-13 | Sale (Planned) | 2,500 | $2.97 | $7,420.00 | (< 1%) 7.45M to 7.45M | |
| 28-May-13 5:25 PM View: | Invivo Therapeutics Holding... (NVIV) | 23-May-13 | Sale (Planned) | 2,500 | $2.90 | $7,250.00 | (< 1%) 7.45M to 7.45M | |
| 22-May-13 7:47 PM View: | Invivo Therapeutics Holding... (NVIV) | 22-May-13 | Sale (Planned) | 2,500 | $2.89 | $7,220.00 | (< 1%) 7.46M to 7.45M | |
| 22-May-13 7:47 PM View: | Invivo Therapeutics Holding... (NVIV) | 21-May-13 | Sale (Planned) | 2,500 | $2.87 | $7,180.00 | (< 1%) 7.46M to 7.46M | |
| 22-May-13 7:47 PM View: | Invivo Therapeutics Holding... (NVIV) | 20-May-13 | Sale (Planned) | 2,500 | $2.88 | $7,210.00 | (< 1%) 7.46M to 7.46M | |
| 17-May-13 4:41 PM View: | Invivo Therapeutics Holding... (NVIV) | 17-May-13 | Sale (Planned) | 2,500 | $2.86 | $7,157.00 | (< 1%) 7.46M to 7.46M | |
| 17-May-13 4:41 PM View: | Invivo Therapeutics Holding... (NVIV) | 16-May-13 | Sale (Planned) | 2,500 | $2.84 | $7,090.00 | (< 1%) 7.47M to 7.46M | |
| 17-May-13 4:41 PM View: | Invivo Therapeutics Holding... (NVIV) | 15-May-13 | Sale (Planned) | 2,500 | $2.85 | $7,115.00 | (< 1%) 7.47M to 7.47M | |
| 14-May-13 4:32 PM View: | Invivo Therapeutics Holding... (NVIV) | 14-May-13 | Sale (Planned) | 2,500 | $2.85 | $7,125.00 | (< 1%) 7.47M to 7.47M | |
| 14-May-13 4:32 PM View: | Invivo Therapeutics Holding... (NVIV) | 13-May-13 | Sale (Planned) | 2,500 | $3.00 | $7,500.00 | (< 1%) 7.47M to 7.47M | |
| 14-May-13 4:32 PM View: | Invivo Therapeutics Holding... (NVIV) | 10-May-13 | Sale (Planned) | 2,500 | $2.89 | $7,237.00 | (< 1%) 7.48M to 7.47M | |
| 09-May-13 6:08 PM View: | Invivo Therapeutics Holding... (NVIV) | 09-May-13 | Sale (Planned) | 2,500 | $2.94 | $7,338.00 | (< 1%) 7.48M to 7.48M | |
| 09-May-13 6:08 PM View: | Invivo Therapeutics Holding... (NVIV) | 08-May-13 | Sale (Planned) | 2,500 | $2.86 | $7,145.00 | (< 1%) 7.48M to 7.48M |